2021 annual financial data
Pacific Biosciences of California 2021 Operating cash flow growth
Direct answer
Operating cash flow growth was -670.07%.
Operating income was -210,435,000 USD and net income was -181,223,000 USD.
Operating cash flow was -111,180,000 USD.
Get free Pacific Biosciences of California email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 130,513,000 USD
- Operating income
- -210,435,000 USD
- Net income
- -181,223,000 USD
- Operating cash flow
- -111,180,000 USD